|
66
|
269
|
4nqdA |
Crystal structure of tcr-mr1 ternary complex and non-covalently bound 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil |
|
68
|
270
|
4nqcA |
Crystal structure of tcr-mr1 ternary complex and covalently bound 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil |
|
67
|
276
|
4no0A |
Crystal structure of non-phosphorylated form of rqa_v phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
70
|
270
|
4nqeA |
Crystal structure of tcr-mr1 ternary complex bound to 5-(2-oxoethylideneamino)-6-d-ribitylaminouracil |
|
81
|
274
|
4no3A |
Crystal structure of ampd2 phosphopeptide bound to hla-a2 |
|
52
|
174
|
4n5eA |
42f3 tcr pcpa12/h-2ld complex |
|
76
|
274
|
4o2eA |
A peptide complexed with hla-b*3901 |
|
62
|
276
|
4nskA |
Crystal structure of the murine class i major histocompatibility complex h-2db in complex with lcmv-derived gp33 altered peptide ligand v3p |
|
78
|
275
|
4no5A |
Crystal structure of non-phosphorylated form of ampd2 phosphopeptide bound to hla-a2 |
|
56
|
203
|
4nhuE |
The m33 tcr p3m33l/h-2 ld complex |
|
79
|
274
|
4nnxA |
Crystal structure of pkd2 phosphopeptide bound to hla-a2 |
|
77
|
274
|
4nnyA |
Crystal structure of non-phosphorylated form of pkd2 phosphopeptide bound to hla-a2 |
|
80
|
274
|
4n8vA |
Crystal structure of killer cell immunoglobulin-like receptor kir2ds2 in complex with hla-a |
|
76
|
274
|
4o2fA |
A peptide complexed with hla-b*3901 |
|
73
|
274
|
4nt6A |
Hla-c*0801 crystal structure |
|
59
|
264
|
4n0uA |
Ternary complex between neonatal fc receptor, serum albumin and fc |
|
58
|
264
|
4n0fA |
Human fcrn complexed with human serum albumin |
|
50
|
174
|
4mxqA |
42f3 tcr pcpc5/h-2ld complex |
|
52
|
174
|
4n0cA |
42f3 tcr pcpe3/h-2ld complex |
|
76
|
273
|
4mx7A |
Structure of mouse cd1d in complex with dioleoyl-phosphatidic acid |
|
73
|
276
|
4mnqA |
Tcr-peptide specificity overrides affinity enhancing tcr-mhc interactions |
|
79
|
274
|
4lcyA |
Crystal structure of hla-b46 at 1.6 angstrom resolution |
|
51
|
176
|
4ms8A |
42f3 tcr pcpb9/h-2ld complex |
|
73
|
274
|
4mj5A |
Crystal structure of hla-a*1101 in complex with h1-22, an influenza a(h1n1) virus epitope |
|
65
|
273
|
4mq7A |
Structure of human cd1d-sulfatide |
|
59
|
276
|
4mjiA |
T cell response to a hiv reverse transcriptase epitope presented by the protective allele hla-b*51:01 |
|
67
|
273
|
4mngA |
Structure of the dp10.7 tcr with cd1d-sulfatide |
|
80
|
276
|
4lnrA |
The structure of hla-b*35:01 in complex with the peptide (rpqvplrpmty) |
|
46
|
174
|
4mvbA |
42f3 pcpb7/h-2ld complex |
|
76
|
274
|
4mj6A |
Crystal structure of hla-a*1101 in complex with h7-22, an influenza a(h7n9) virus epitope |
|
80
|
384
|
4lccC |
Crystal structure of a human mait tcr in complex with a bacterial antigen bound to humanized bovine mr1 |
|
73
|
276
|
4l3cA |
Structure of hla-a2 in complex with d76n b2m mutant and ny-eso1 double mutant |
|
73
|
269
|
4l4vA |
Structure of human mait tcr in complex with human mr1-rl-6-me-7-oh |
|
65
|
264
|
4k71B |
Crystal structure of a high affinity human serum albumin variant bound to the neonatal fc receptor |
|
68
|
272
|
4lhuA |
Crystal structure of 9c2 tcr bound to cd1d |
|
74
|
277
|
4l8dA |
Crystal structure of the h2db in complex with the np-n5d peptide |
|
72
|
270
|
4l4tA |
Structure of human mait tcr in complex with human mr1-6-fp |
|
78
|
274
|
4k7fA |
Newly identified epitope v60 from hbv core protein complexed with hla-a*0201 |
|
71
|
270
|
4lcwA |
The structure of human mait tcr in complex with mr1-k43a-rl-6-me-7oh |
|
75
|
276
|
4l29A |
Structure of wtmhc class i with ny-eso1 double mutant |
|
80
|
385
|
4l8sC |
Crystal structure of a human valpha7.2/vbeta13.3 mait tcr in complex with bovine mr1 |
|
71
|
385
|
4l9lC |
Crystal structure of a human valpha7.2/vbeta13.2 mait tcr in complex with bovine mr1 |
|
71
|
276
|
4l8bA |
Crystal structure of the h2db in complex with the np-n5h peptide |
|
73
|
275
|
4l3eA |
The complex between high affinity tcr dmf5(alpha-d26y,beta-l98w) and human class i mhc hla-a2 with the bound mart-1(26-35)(a27l) peptide |
|
81
|
276
|
4jqxA |
Hla-b*44:03 in complex with epstein-barr virus bzlf1-derived peptide (residues 169-180) |
|
67
|
276
|
4jffA |
Preservation of peptide specificity during tcr-mhc contact dominated affinity enhancement of a melanoma-specific tcr |
|
75
|
273
|
4irjA |
Structure of the mouse cd1d-4clphc-alpha-galcer-inkt tcr complex |
|
79
|
274
|
4hx1A |
Structure of hla-a68 complexed with a tumor antigen derived peptide |
|
78
|
276
|
4jqvA |
Hla-b*18:01 in complex with epstein-barr virus bzlf1-derived peptide (residues 173-180) |
|
67
|
276
|
4jfeA |
Preservation of peptide specificity during tcr-mhc contact dominated affinity enhancement of a melanoma-specific tcr |
